Viewing Study NCT06043193


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-05-26 @ 1:13 AM
Study NCT ID: NCT06043193
Status: RECRUITING
Last Update Posted: 2025-06-11
First Post: 2023-08-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region.
Sponsor: Hospices Civils de Lyon
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 69HCL23_0367
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators